DPIIT recognised startup Government of India
Startup India
Curo Biosciences Private Limited - healthcare in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.52 Lakh
▲ 6% YoY
Net loss · FY 2024
₹43.54 Lakh
Latest filing
EBITDA · FY 2024
-₹37.3 Lakh
Latest filing
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1.62 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Curo Biosciences Private Limited
Data last updated:
Curo Biosciences Private Limited is a private limited company based in Nagpur, Maharashtra, India, recognised as a startup by DPIIT. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 14 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2019PTC329302. Its GSTIN is 27AAICC3296R1ZT (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.62 Lakh. It is led by directors Pradnya Anil Mahatme and Shubhendrasingh Jitendrasingh Thakur.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 41 H.No. 1408/A Darshana Society Mouja Gorewada, Nagpur, Maharashtra, India – 440013.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.52 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹43.54 Lakh and EBITDA of -₹37.3 Lakh. Revenue has grown at a compounded annual rate (CAGR) of 112% over three years.
The company is associated with 1 brand: Erly Sign. The company has 1 deal on record (1 funding round), with disclosed funding of ₹16 Cr; the latest was in January 2025.
Curo Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0024907). For more details, the company can be reached via its website erlysign.com.
Company details
CIN U85300MH2019PTC329302
Registration Number 329302
Incorporation Date 14 August 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0024907
Recognitions & Rankings of Curo Biosciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0024907
Contact details
Curo Biosciences Private Limited's registered office is in Nagpur, Maharashtra. Its website is erlysign.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 41 H.No. 1408/A Darshana Society Mouja Gorewada, Nagpur, Maharashtra, India – 440013
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Curo Biosciences Private Limited, buy the company report.
Comprehensive company report
Curo Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Curo Biosciences operates one associated brand: Erly Sign. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A platform providing test kits for detecting oral cancer | erlysign.com |
Financials of Curo Biosciences Private Limited
FY 2024 filings availableCuro Biosciences Private Limited reported revenue of ₹3.52 Lakh (up 6% YoY) for FY 2024.
Revenue · FY 2024
₹3.52 Lakh ▲ 6%
Net loss · FY 2024
₹43.54 Lakh
EBITDA · FY 2024
-₹37.3 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 112%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 48%
Revenue has grown at a compounded annual rate (CAGR) of 112% over three years, including 6% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹37.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹43.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curo Biosciences Private Limited, buy the company report.
Board of directors of Curo Biosciences Private Limited
Curo Biosciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradnya Anil Mahatme Also directs: GDD Experts India Private Limited | Director | 20 Apr 2022 | 4 Years 6 Months | Current |
| Shubhendrasingh Jitendrasingh Thakur | Director | 14 Aug 2019 | 7 Years 2 Months | Current |
Auditor
Curo Biosciences Private Limited is audited by A.S. SONI & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.S. SONI & COMPANY | FY 2023 | 152237 |
Shareholding
The shareholding of Curo Biosciences Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Curo Biosciences Private Limited, buy the company report.
Deals & funding
Curo Biosciences Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹16 Cr; the latest was in January 2025.
Total deals
1
Funding round
1
Disclosed funding
₹16 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2025 | Funding round · Pre-Series A | ₹16 Cr | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Curo Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curo Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Curo Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICC3296R1ZT | Maharashtra | Active | 15 Oct 2019 |
To see the full GST registrations and return filing status of Curo Biosciences Private Limited, buy the company report.
Recent activity
Curo Biosciences Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Pradnya Anil Mahatme ceased to be Additional Director on 30 Sep 2022.
AGM
Curo Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Curo Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Pradnya Anil Mahatme ceased to be Additional Director.
Appointed
Pradnya Anil Mahatme was appointed as Director.
Ceased
Pritish Prabhakaran Nelleri ceased to be Director.
Ceased
Shruthi Hemanshu Jain ceased to be Additional Director.
Appointed
Shubhendrasingh Jitendrasingh Thakur was appointed as Director.
Incorporation
14 Aug 2019
Curo Biosciences Private Limited was registered on 14 Aug 2019 with Roc Mumbai & aged 7 years 2 months as per MCA records.
News
Frequently asked questions
Curo Biosciences is an active private limited company based in Nagpur, Maharashtra, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 14 August 2019 (7+ years old) and is registered under CIN U85300MH2019PTC329302.
Curo Biosciences has 2 current directors:
- Pradnya Anil Mahatme - Director
- Shubhendrasingh Jitendrasingh Thakur - Director
The latest financial statements of Curo Biosciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Curo Biosciences is 27AAICC3296R1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Curo Biosciences is U85300MH2019PTC329302. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curo Biosciences was incorporated on 14 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Curo Biosciences has 1 deal on record (1 funding round), with disclosed funding of ₹16 Cr; the latest was in January 2025.
Pradnya Anil Mahatme ceased to be Additional Director on 30 Sep 2022. Pradnya Anil Mahatme was appointed as Director on 20 Apr 2022. Pritish Prabhakaran Nelleri ceased to be Director on 20 Apr 2022. Curo Biosciences has 5 board changes on record in total.
Yes, Curo Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Curo Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0024907).